Q2 2024 · 13F-HR
Lion Point Capital, LPholdings as filed
Filed 2024-08-14 · accession 0001013594-24-000659
$54.9M
Reported value
27
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 464287655 | IWM | ISHARES TR | $16.7M | 30.5% | 82,500 | PUT | SOLE |
| 039697107 | ARDX | ARDELYX INC | $6.3M | 11.6% | 856,667 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $4.7M | 8.59% | 70,335 | Common | SOLE |
| 78464A870 | XBI | SPDR SER TR | $4.6M | 8.45% | 50,000 | PUT | SOLE |
| 59935V107 | MIST | MILESTONE PHARMACEUTICALS IN | $3.1M | 5.63% | 2,340,207 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $2.7M | 4.87% | 630,000 | Common | SOLE |
| 56854Q200 | MRNS* | MARINUS PHARMACEUTICALS INC | $2.5M | 4.51% | 2,114,827 | Common | SOLE |
| G52694109 | KNSA | KINIKSA PHARMACEUTICALS INTL | $2.0M | 3.56% | 104,691 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $1.5M | 2.80% | 45,000 | PUT | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $1.3M | 2.43% | 65,000 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $1.2M | 2.26% | 49,000 | Common | SOLE |
| G29687103 | AVDL | AVADEL PHARMACEUTICALS PLC | $1.2M | 2.11% | 82,500 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $1.1M | 2.10% | 8,350 | Common | SOLE |
| 31447P100 | FENC | FENNEC PHARMACEUTICALS INC | $1.0M | 1.89% | 170,000 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $924,300 | 1.69% | 79,000 | Common | SOLE |
| G3167L109 | — | ENPHYS ACQUISITION CORP | $857,813 | 1.56% | 78,125 | Common | SOLE |
| 471871202 | JSPR | JASPER THERAPEUTICS INC | $726,400 | 1.32% | 32,000 | Common | SOLE |
| 09609G100 | — | BLUEBIRD BIO INC | $667,540 | 1.22% | 678,256 | Common | SOLE |
| 12122L101 | 0LS | BURGERFI INTERNATIONAL INC | $557,425 | 1.02% | 2,745,938 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $424,125 | 0.77% | 36,250 | Common | SOLE |
| 81750R102 | MCRB1EUR | SERES THERAPEUTICS INC | $246,643 | 0.45% | 340,761 | Common | SOLE |
| 55028X109 | 4NX1 | LUMOS PHARMA INC | $210,642 | 0.38% | 90,794 | Common | SOLE |
| 594918104 | MSFT | MICROSOFT CORP | $44,695 | 0.08% | 100 | Common | SOLE |
| 85209E109 | — | SPRUCE BIOSCIENCES INC | $38,828 | 0.07% | 75,000 | Common | SOLE |
| 12122L119 | — | BURGERFI INTERNATIONAL INC | $26,251 | 0.05% | 2,083,438 | Common | SOLE |
| 07134L107 | BATL | BATTALION OIL CORP | $24,793 | 0.05% | 7,423 | Common | SOLE |
| 02079K107 | GOOG | ALPHABET INC | $18,342 | 0.03% | 100 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.